Do analysts prefer JG or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Mobile 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate PHUN or ADVB?

Phunware currently has a consensus price target of $2.00, suggesting a potential downside of 1.96%. Given Phunware's stronger consensus rating and higher possible upside, research analysts clearly believe Phunware is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phunware 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate PXLW or ADVB?

Pixelworks presently has a consensus target price of $12.00, indicating a potential upside of 124.30%. Given Pixelworks' stronger consensus rating and higher probable upside, analysts clearly believe Pixelworks is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pixelworks 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is PXLW or ADVB more profitable?

Advanced Biomed's return on equity of 87.74% beat Pixelworks' return on equity. Company Net Margins Return on Equity Return on Assets Pixelworks N/A -28.77% -14.64% Advanced Biomed N/A 87.74% 64.49%

Do analysts rate ADVB or LPSN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ADVB or DGNX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Diginex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, ADVB or DGNX?

Advanced Biomed has higher earnings, but lower revenue than Diginex. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advanced Biomed $130K 65.24 -$3.26M $4.82 1.07 Diginex $3.62M 9.41 -$31.15M N/A N/A

Is ADVB or DGNX more profitable?

Advanced Biomed's return on equity of 87.74% beat Diginex's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% Diginex N/A N/A N/A

Advanced Biomed (ADVB) Competitors

$4.99 -0.16 (-3.02%)

As of 02:46 PM Eastern

Compare

ADVB vs. JG, PHUN, PXLW, LPSN, and DGNX

Should you buy Advanced Biomed stock or one of its competitors? Advanced Biomed's main competitors and comparable companies include Aurora Mobile (JG), Phunware (PHUN), Pixelworks (PXLW), LivePerson (LPSN), and Diginex (DGNX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Advanced Biomed compare to Aurora Mobile?

Aurora Mobile (NASDAQ:JG) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Mobile	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Aurora Mobile has a net margin of 1.53% compared to Advanced Biomed's net margin of 0.00%. Advanced Biomed's return on equity of 87.74% beat Aurora Mobile's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Mobile	1.53%	6.23%	1.50%
Advanced Biomed	N/A	87.74%	64.49%

85.5% of Aurora Mobile shares are owned by institutional investors. 31.2% of Aurora Mobile shares are owned by insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Aurora Mobile has higher revenue and earnings than Advanced Biomed. Advanced Biomed is trading at a lower price-to-earnings ratio than Aurora Mobile, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Mobile	$390.54M	0.13	$60K	$0.18	46.17
Advanced Biomed	$130K	65.24	-$3.26M	$4.82	1.07

Aurora Mobile has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

In the previous week, Aurora Mobile had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 4 mentions for Aurora Mobile and 3 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.80 beat Aurora Mobile's score of 0.71 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Mobile	Positive
Advanced Biomed	Positive

Summary

Aurora Mobile beats Advanced Biomed on 9 of the 14 factors compared between the two stocks.

How does Advanced Biomed compare to Phunware?

Phunware (NASDAQ:PHUN) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Advanced Biomed has a net margin of 0.00% compared to Phunware's net margin of -471.72%. Advanced Biomed's return on equity of 87.74% beat Phunware's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phunware	-471.72%	-13.79%	-12.37%
Advanced Biomed	N/A	87.74%	64.49%

Phunware currently has a consensus price target of $2.00, suggesting a potential downside of 1.96%. Given Phunware's stronger consensus rating and higher possible upside, research analysts clearly believe Phunware is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phunware	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Advanced Biomed had 2 more articles in the media than Phunware. MarketBeat recorded 3 mentions for Advanced Biomed and 1 mentions for Phunware. Advanced Biomed's average media sentiment score of 0.80 beat Phunware's score of 0.45 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Overall Sentiment
Phunware	Neutral
Advanced Biomed	Positive

Advanced Biomed has lower revenue, but higher earnings than Phunware. Phunware is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phunware	$2.55M	16.37	-$11.40M	-$0.65	N/A
Advanced Biomed	$130K	65.24	-$3.26M	$4.82	1.07

7.6% of Phunware shares are owned by institutional investors. 0.2% of Phunware shares are owned by company insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Phunware has a beta of 2.59, suggesting that its stock price is 159% more volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

Summary

Advanced Biomed beats Phunware on 9 of the 14 factors compared between the two stocks.

How does Advanced Biomed compare to Pixelworks?

Pixelworks (NASDAQ:PXLW) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Advanced Biomed has lower revenue, but higher earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pixelworks	$690K	46.91	-$22.50M	-$1.63	N/A
Advanced Biomed	$130K	65.24	-$3.26M	$4.82	1.07

Pixelworks has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.01, suggesting that its share price is 99% less volatile than the broader market.

21.4% of Pixelworks shares are held by institutional investors. 4.7% of Pixelworks shares are held by insiders. Comparatively, 27.0% of Advanced Biomed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Pixelworks and Pixelworks both had 3 articles in the media. Advanced Biomed's average media sentiment score of 0.80 beat Pixelworks' score of 0.37 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Overall Sentiment
Pixelworks	Neutral
Advanced Biomed	Positive

Pixelworks presently has a consensus target price of $12.00, indicating a potential upside of 124.30%. Given Pixelworks' stronger consensus rating and higher probable upside, analysts clearly believe Pixelworks is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pixelworks	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed's return on equity of 87.74% beat Pixelworks' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pixelworks	N/A	-28.77%	-14.64%
Advanced Biomed	N/A	87.74%	64.49%

Summary

Advanced Biomed beats Pixelworks on 7 of the 13 factors compared between the two stocks.

How does Advanced Biomed compare to LivePerson?

Advanced Biomed (NASDAQ:ADVB) and LivePerson (NASDAQ:LPSN) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Advanced Biomed has a net margin of 0.00% compared to LivePerson's net margin of -51.89%. Advanced Biomed's return on equity of 87.74% beat LivePerson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
LivePerson	-51.89%	N/A	-8.39%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

79.8% of LivePerson shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by insiders. Comparatively, 2.0% of LivePerson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Advanced Biomed has a beta of 0.01, indicating that its stock price is 99% less volatile than the broader market. Comparatively, LivePerson has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

Advanced Biomed has higher earnings, but lower revenue than LivePerson. LivePerson is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	$130K	65.24	-$3.26M	$4.82	1.07
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A

In the previous week, Advanced Biomed had 2 more articles in the media than LivePerson. MarketBeat recorded 3 mentions for Advanced Biomed and 1 mentions for LivePerson. LivePerson's average media sentiment score of 1.60 beat Advanced Biomed's score of 0.80 indicating that LivePerson is being referred to more favorably in the news media.

Company	Overall Sentiment
Advanced Biomed	Positive
LivePerson	Very Positive

Summary

Advanced Biomed beats LivePerson on 9 of the 13 factors compared between the two stocks.

How does Advanced Biomed compare to Diginex?

Advanced Biomed (NASDAQ:ADVB) and Diginex (NASDAQ:DGNX) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

Advanced Biomed's return on equity of 87.74% beat Diginex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Diginex	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Diginex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Advanced Biomed and Advanced Biomed both had 3 articles in the media. Advanced Biomed's average media sentiment score of 0.80 beat Diginex's score of 0.45 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
Diginex	Neutral

Advanced Biomed has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market. Comparatively, Diginex has a beta of -2.79, suggesting that its stock price is 379% less volatile than the broader market.

Advanced Biomed has higher earnings, but lower revenue than Diginex.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	$130K	65.24	-$3.26M	$4.82	1.07
Diginex	$3.62M	9.41	-$31.15M	N/A	N/A

Summary

Advanced Biomed beats Diginex on 6 of the 7 factors compared between the two stocks.

Get Advanced Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADVB vs. The Competition

Export

Metric	Advanced Biomed	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$8.24M	$16.67B	$29.80B	$12.89B
Dividend Yield	N/A	3.42%	2.76%	19.59%
P/E Ratio	1.03	143.36	78.16	25.25
Price / Sales	64.52	1,269.67	576.56	74.93
Price / Cash	N/A	46.54	49.01	52.75
Price / Book	1.55	8.86	7.70	5.99
Net Income	-$3.26M	$429.53M	$767.06M	$380.68M
7 Day Performance	-18.55%	-0.86%	-3.64%	-3.34%
1 Month Performance	-38.30%	-0.99%	-2.89%	-5.88%
1 Year Performance	N/A	0.02%	160.97%	-5.63%

Advanced Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADVB Advanced Biomed	0.9276 of 5 stars	$4.99 -3.0%	N/A	N/A	$8.24M	$127.64K	1.03	31	Earnings Report Short Interest Increase
JG Aurora Mobile	1.6697 of 5 stars	$7.09 +1.3%	N/A	+1.5%	$41.99M	$53.60M	39.39	421	Analyst Upgrade Gap Down Trading Halted
PHUN Phunware	0.5029 of 5 stars	$2.07 +1.5%	$2.00 -3.4%	-31.1%	$41.74M	$2.55M	N/A	26
PXLW Pixelworks	2.7894 of 5 stars	$6.36 -4.4%	$16.00 +151.6%	-64.2%	$40.23M	$690K	N/A	163
LPSN LivePerson	0.2878 of 5 stars	$3.10 flat	N/A	N/A	$38.25M	$228.89M	N/A	1,540	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADVB) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Advanced Biomed (ADVB) Competitors

ADVB vs. JG, PHUN, PXLW, LPSN, and DGNX

How does Advanced Biomed compare to Aurora Mobile?

Summary

How does Advanced Biomed compare to Phunware?

Summary

How does Advanced Biomed compare to Pixelworks?

Summary

How does Advanced Biomed compare to LivePerson?

Summary

How does Advanced Biomed compare to Diginex?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Advanced Biomed (ADVB) Competitors

ADVB vs. JG, PHUN, PXLW, LPSN, and DGNX

How does Advanced Biomed compare to Aurora Mobile?

Do analysts prefer JG or ADVB?

Is JG or ADVB more profitable?

Do insiders & institutionals hold more shares of JG or ADVB?

Which has better valuation and earnings, JG or ADVB?

Which has more volatility and risk, JG or ADVB?

Does the media favor JG or ADVB?

Summary

How does Advanced Biomed compare to Phunware?

Is PHUN or ADVB more profitable?

Do analysts rate PHUN or ADVB?

Does the media favor PHUN or ADVB?

Which has higher earnings & valuation, PHUN or ADVB?

Do institutionals and insiders hold more shares of PHUN or ADVB?

Which has more volatility & risk, PHUN or ADVB?

Summary

How does Advanced Biomed compare to Pixelworks?

Which has higher earnings and valuation, PXLW or ADVB?

Which has more volatility & risk, PXLW or ADVB?

Do insiders and institutionals have more ownership in PXLW or ADVB?

Does the media favor PXLW or ADVB?

Do analysts rate PXLW or ADVB?

Is PXLW or ADVB more profitable?

Summary

How does Advanced Biomed compare to LivePerson?

Is ADVB or LPSN more profitable?

Do analysts rate ADVB or LPSN?

Do institutionals & insiders hold more shares of ADVB or LPSN?

Which has more risk and volatility, ADVB or LPSN?

Which has better earnings & valuation, ADVB or LPSN?

Does the media prefer ADVB or LPSN?

Summary

How does Advanced Biomed compare to Diginex?

Is ADVB or DGNX more profitable?

Do analysts rate ADVB or DGNX?

Does the media refer more to ADVB or DGNX?

Which has more risk & volatility, ADVB or DGNX?

Which has higher valuation and earnings, ADVB or DGNX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools